Keywords: سندرم میلودیسپلاستیک; Cancer stem cell; Chemotherapy; Chemoresistance; Targeted therapy; 5-FU; 5-fluorouracil; ABCT; ATP-binding cassette transporter; ALDH; Aldehyde dehydrogenase; AML; Acute myeloid leukemia; ASC; Adult stem cell; BCRP or ABCG; Breast cancer resistance protei
مقالات ISI سندرم میلودیسپلاستیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سندرم میلودیسپلاستیک; ACI; anemia of chronic inflammation; AD[H]D; attention deficit[/hyperactivity] disorder; ASD; autism spectrum disorder; BMS; burning mouth syndrome; BPAD; bipolar affective disorder; CCS; Cronkhite-Canada syndrome; CFS; chronic fatigue syndrome; CGRP; cal
Keywords: سندرم میلودیسپلاستیک; AML; acute myeloid leukemia; CI; Confidence Interval; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; IRB; Institutional Review Board; MDS; myelodysplastic syndrome; Non-CLL; non-chronic lymphocytic leukemia; OR; odds ratio; RADRUE; Real
Keywords: سندرم میلودیسپلاستیک; Azacitidine; Cytogenetics; Dose adjustment; Infection; Myelodysplastic syndrome
Keywords: سندرم میلودیسپلاستیک; granulocytic sarcoma; Koebner phenomenon; myelodysplastic syndrome; transforming growth factor-beta 1 pathway; CGS; cutaneous granulocytic sarcoma; GS; granulocytic sarcoma; IHC; immunohistochemistry; KP; Koebner phenomenon; MDS; myelodysplastic syndrom
Keywords: سندرم میلودیسپلاستیک; SM; systemic mastocytosis; AHNMD; associated clonal haematological non-mast cell lineage disease; CM; cutaneous mastocytosis; RTK; receptor tyrosine kinase; MDS; myelodysplastic syndrome; MPN; myeloproliferative syndrome; AML; acute myeloid leukaemia.; Ma
Keywords: سندرم میلودیسپلاستیک; Acute febrile neutrophilic dermatosis; −5/del(5q); FMS-related tyrosine kinase-3; Myelodysplastic syndrome; Neutrophilic dermatosis
Keywords: سندرم میلودیسپلاستیک; Acute myeloid leukemia; Myelodysplastic syndrome; Cytopenia
Keywords: سندرم میلودیسپلاستیک; AML; adult myeloid leukemia; CI; confidence interval; CR; complete remission; hAML; AML arising from a prior hematologic malignancy; HCTCI; hematopoietic cell transplantation-specific comorbidity index; MDS; myelodysplastic syndrome; OR; odds ratio; OS; o
Keywords: سندرم میلودیسپلاستیک; Decitabine; Stem cell transplantation; Maintenance; Myelodysplastic syndrome; Acute leukemia
Keywords: سندرم میلودیسپلاستیک; Granulocyte colony-stimulating factor; Conditioning regimen; Cord blood transplantation; Myelodysplastic syndrome; Secondary acute myeloid leukemia;
Keywords: سندرم میلودیسپلاستیک; bone marrow; myelodysplastic syndrome; myeloid; pathology
Keywords: سندرم میلودیسپلاستیک; AML; acute myeloid leukemia; BSA; bovine serum albumin; DPF; deferiprone (3-hydroxy-1,2-dimethyl-4-pyridinone); DFO; deferoxamine; ESA; erythropoietic stimulating agents; EDTA; ethylene-diamine tetracetate; FAC; ferric ammonium citrate; FIC; functional ir
Keywords: سندرم میلودیسپلاستیک; Cancer Genomics Consortium; Cancer cytogenomic microarray; Chronic lymphocytic leukemia; Myelodysplastic syndrome; Renal epithelial tumor;
Keywords: سندرم میلودیسپلاستیک; ABCA1; ATP-binding cassette, subfamily A, member 1; ABCG5; ATP-binding cassette, subfamily G, member 5; ACD; anemia of chronic disease; AI; anemia of inflammation; Apo; apolipoprotein; Arg1; arginase-1; Bach1; Btb and Cnc Homology, basic leucine zipper tr
Keywords: سندرم میلودیسپلاستیک; ADA; adenosine deaminase; AIRE; autoimmune regulator; AML; acute myeloid leukemia; APECED; autoimmune polyendocrinopathy, candidiasis, and ectodermal dysplasia; APLAID; autoinflammation and PLCγ2-associated antibody deficiency and immune dysregulation; A
Keywords: سندرم میلودیسپلاستیک; alloSCT; allogeneic stem cell transplant; AML; acute myeloid leukemia; ESA; erythropoiesis-stimulating agent; FDA; Food and Drug Administration; FISH; fluorescence in situ hybridization; G-CSF; granulocyte colony stimulating factor; HSCT; hematopoietic st
Keywords: سندرم میلودیسپلاستیک; HR; hazard ratio; IPSS; International Prognostic Scoring System; IPSS-R; Revised International Prognostic Scoring System; FAB; French American British; LT; leukemic transformation; MDAS; MD Anderson score; MDS; myelodysplastic syndrome; MK; monosomal kary
Keywords: سندرم میلودیسپلاستیک; Chronic myelomonocytic leukemia; Myelodysplastic syndrome; Myeloproliferative neoplasms
Keywords: سندرم میلودیسپلاستیک; Myelodysplastic syndrome; Allogeneic hematopoietic cell transplantation; Relapse; Monosomal karyotype; Cytogenetics; Cytogenetic scoring systems;
Keywords: سندرم میلودیسپلاستیک; α-KG; alpha-ketoglutarate; 2-HG; 2-hydroxyglutarate; 5hmC; 5-hydroxymethylcytosine; 5mC; 5-methylcytosine; AML; acute myeloid leukemia; ASXL1; additional sex combs-like 1; AZA; azacytidine; CMML; chronic myelomonocytic leukemia; DAC; decitabine; DNMT3A;
Keywords: سندرم میلودیسپلاستیک; Clonal hematopoiesis; aplastic anemia; bone marrow failure; myelodysplastic syndrome; MDS;
Keywords: سندرم میلودیسپلاستیک; 4-HPR; N-(4-hydroxyphenyl)retinamide; 5â²-UTR; 5â²-untranslated region; 9-cis-RA; 9-cis retinoic acid; 9cUAB30; (2E,4E,6Z,8E)-8-(3â²,4â²-dihydro-1â²(2'H)-naphthalen-1â²-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid; Acitretin; (2E,4E,6E,8E)-9-(4-met
Keywords: سندرم میلودیسپلاستیک; fertility preservation; myelodysplastic syndrome; oocyte cryopreservation; single embryo transfer
Keywords: سندرم میلودیسپلاستیک; Telomerase activity; Myeloproliferative neoplasm; Essential thrombocythemia; Extreme thrombocytosis; Myelodysplastic syndrome;
Keywords: سندرم میلودیسپلاستیک; Hematopoietic stem cell transplantation; Myelodysplastic syndrome; Aplastic anemia
Keywords: سندرم میلودیسپلاستیک; Minimal residual disease; Chimerism; Allogeneic stem cell transplantation; Acute myeloid leukemia; Myelodysplastic syndrome; Relapse
Keywords: سندرم میلودیسپلاستیک; Myelodysplastic syndrome; Iron overload; Chelation; Survival; Ferritin; Leukemia;
Keywords: سندرم میلودیسپلاستیک; Acute Myeloid Leukemia; Aspergillosis; Azacitidine; Myelodysplastic Syndrome; Prophylaxis;
Keywords: سندرم میلودیسپلاستیک; Acute myelogenous leukemia; Myelodysplastic syndrome; Reduced intensity; Transplantatiom; Alemtuzumab
Keywords: سندرم میلودیسپلاستیک; Myelodysplastic syndrome; Myeloproliferative neoplasm; Nonmyeloablative conditioning
Keywords: سندرم میلودیسپلاستیک; Fanconi anemia; leukemia; myelodysplastic syndrome; bone marrow failure; stem cell transplant
Keywords: سندرم میلودیسپلاستیک; acute myelocytic leukemia; AML; cytokine-induced killer cells; CIK cells; decitabine; elderly; myelodysplastic syndrome; MDS
Keywords: سندرم میلودیسپلاستیک; MDS; Myelodysplastic syndrome; Iron chelation; Iron overload; Transfusion-dependent; Deferasirox; Deferoxamine; Deferiprone
Keywords: سندرم میلودیسپلاستیک; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ASX; additional sex combs; BM; bone marrow; bZIP; leucine zipper; C/EBPα; CCAAT/enhancer binding protein α; CN-AML; normal karyotype-AML; CR; complete remissions; DFS; disease-free survival
Keywords: سندرم میلودیسپلاستیک; ÎKG; α-ketoglutarate; AML; acute myeloid leukemia; BCAT1; branched-chain amino acid transporter 1; BRD4; bromodomain-containing protein 4; D-2HG; D-2-hydroxyglutarate or R-2-hydroxyglutarate; D-2HGA; D-2-hydroxyglutarate aciduria; D2HGDH; D-2-hydroxyglu
Keywords: سندرم میلودیسپلاستیک; Myelodysplastic syndrome; Autoimmune diseases; Outcome; Hypomethylating agents; Treatment;
Keywords: سندرم میلودیسپلاستیک; Therapy-related myelodysplastic syndrome; Myelodysplastic syndrome; Therapy-related myeloid neoplasms; Azacitidine;
Keywords: سندرم میلودیسپلاستیک; IDO; Myelodysplastic syndrome; Kynurenine; Tryptophan; Hematopoiesis;
Keywords: سندرم میلودیسپلاستیک; Myelodysplastic Syndrome; Ascorbate; Dehydroascorbate; Oxidative stress; Apoptosis; Anti-cancer therapy;
Keywords: سندرم میلودیسپلاستیک; Peripheral blood; Myelodysplastic syndrome; Chromosomal microarray analysis; Single nucleotide polymorphism; Whole genome scanning
Keywords: سندرم میلودیسپلاستیک; Micromegakaryocytes; Thrombocytopenia; Myelodysplastic syndrome; Refractory cytopenia of childhood; Marrow fibrosis
“Reversible” myelodysplastic syndrome or ineffectual clonal haematopoiesis? - add(6p) myeloid neoplasm with a spontaneous cytogenetic remission
Keywords: سندرم میلودیسپلاستیک; Therapy-related myeloid neoplasm; Myelodysplastic syndrome; CHIP; MDS; AML; Clonal haematopoiesis; der(6)t(6;13);
Predicted indirectly recognizable HLA epitopes are not associated with clinical outcomes after haploidentical hematopoietic stem cell transplantation
Keywords: سندرم میلودیسپلاستیک; HLA allele; PIRCHE; Haploidentical; Outcome; haplo-SCT; Haploidentical stem cell transplantation; HLA; human leukocyte antigen; PIRCHE; Predicted Indirectly ReCognizable HLA Epitopes; GVHD; chronic graft-versus-host disease; AML; acute myeloid leukemia; A
Trasplante de células madre hematopoyéticas en pacientes pediátricos con diagnóstico de neoplasias mieloides, experiencia en 15 años
Keywords: سندرم میلودیسپلاستیک; Trasplante de células madre hematopoyéticas; Leucemia mieloide; SÃndrome mielodisplásico; Supervivencia; Infección; Haematopoietic stem cell transplantation; Myeloid leukaemia; Myelodysplastic syndrome; Survival; Infection;
Anti-c-Mpl antibodies in immune thrombocytopenia suppress thrombopoiesis and decrease response to rhTPO
Keywords: سندرم میلودیسپلاستیک; (anti-c-Mpl) antibodies; anti-TPO receptor; anti-c-Mpl+; anti-c-Mpl-antibody-positive; anti-c-Mplâ; anti-c-Mpl-antibody-negative; ITP; immune thrombocytopenia; IVIG; intravenous immunoglobulin; TPO; thrombopoietin; TPO-RAs; TPO receptor agonists; rhTPO;
Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature
Keywords: سندرم میلودیسپلاستیک; Acute myelocytic leukemia (AML); Secondary clone; Myelodysplastic syndrome (MDS); Therapy-related acute myelocytic leukemia (t-AML); Therapy-related myelodysplastic syndrome (t-MDS); AML; acute myelocytic leukemia; APL; acute promyelocytic leukemia; ATO;
A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia
Keywords: سندرم میلودیسپلاستیک; Rigosertib; Myelodysplastic syndrome; Acute myeloid leukemia; Refractory; Cell cycle; Ras inhibitor;
Double sword role of EZH2 in leukemia
Keywords: سندرم میلودیسپلاستیک; EZH1,2; enhancer of Zeste 1 and 2; SUZ12; suppressor of zeste 12 homolog; EED; embryonic ectoderm development; AEBP2; adipocyte enhancer-binding protein 2; RBAP46/48; retinoblastoma binding proteins 46 and 48; PRC; polycomb-repressive complex; PcG; Polyco
Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia
Keywords: سندرم میلودیسپلاستیک; Bone marrow failure; Myelodysplastic syndrome; Leukemia; Exquisite therapeutic sensitivity; DNA repair; BRCA1/2; Fanconi complex; Fanconi anemia;